Status:
COMPLETED
Breast Localization: RFID Tags vs Wire Localization
Lead Sponsor:
Centre Jean Perrin
Conditions:
Breast Neoplasm Female
Eligibility:
FEMALE
18+ years
Brief Summary
The RFID trial focuses on breast localization in patients with non-palpable breast cancers. It aims to demonstrate the improvement in patient comfort when using the Radio Frequency Identification (RFI...
Detailed Description
It is an observational, prospective, single-center, 2-arm (RFID group vs. standard gold), non-randomized and category 3 comparative study. The RFID trial focuses on breast localization in patients wit...
Eligibility Criteria
Inclusion
- Patients 18 years of age or older,
- Requiring conservative surgical management for a breast lesion -infra-clinical (fibroadenomas, papillomas, atypical lesions, neoplasia), whose histology will have been proven beforehand by anatomopathology.
- Patients referred to mastology for preoperative identification by the surgeons
- Able to give informed consent to participate in the research.
- Affiliation to a Social Security regime
Exclusion
- Multiple breast lesions
- Patients with breast neoplasia during pregnancy.
- Person deprived of liberty or under guardianship or incapable of giving consent
- Refusal to participate
Key Trial Info
Start Date :
May 15 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 24 2023
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04750889
Start Date
May 15 2021
End Date
April 24 2023
Last Update
June 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Jean PERRIN
Clermont-Ferrand, France, 63011